logo
15:57 Jun 24

Beta Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2164.40
+71.20 (+3.40%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Beta Drugs Ltd. Financials

Beta Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2164.40
+71.20 (+3.40%)
15:57 Jun 24
Quality
image/svg+xml

36/100
Medium Financial Strength

Valuation
image/svg+xml

27/100
Expensive Valuation

Technical

63/100
Technically Moderately Bullish

Strength

8

Weakness

9

Opportunity

1

Threats

0

16.94 %

ROE %

8.36 %

ROA %

39.97

EPS

241.46

BVPS

10.77 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
183.84 227.11 295.71 362.36 384.83
Operating Expenses +
141.14 173.99 235.72 287.75 309.15
Raw Material
96.21 110.4 167.65 175.78 173.81
Increase Decrease in Cost
-1.75 -4.71 -18.24 -4.42 -2.63
Other Manufacturing Expense
17.78 24.29 31.79 40.62 0
Employee Cost
15.91 22.7 25.89 33.92 68.01
Miscellaneous Expenses
12.99 21.31 28.63 41.85 69.96
Operating Profit
42.7 53.12 59.99 74.61 75.68
Other Income
0.76 0.75 1.36 6.44 11.18
Depreciation
7.25 10.41 9.78 12.51 17.15
Interest
1.9 2.41 2.82 6.99 15.31
Profit before tax and exceptio..
34.3 41.06 48.75 61.54 54.39
Exceptional Items
0 0 0 -4.57 0
PBT
34.3 41.06 48.75 56.97 54.39
Provision for Taxation
9.47 10.34 12.32 14.55 12.91
Net Profit
24.83 30.72 36.44 42.42 41.48
NET Profit after MI
24.83 30.72 36.44 42.42 41.48
EPS
25.82 31.95 37.9 42.02 40.92
Operating Profit Margin (%)
23.23 23.39 20.29 20.59 19.67
Net Profit Margin (%)
13.51 13.53 12.32 11.71 10.78

Beta Drugs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 64.60 64.90 66.70 66.70 66.70 66.70
FII 1.20 1.10 0.90 0.90 0.90 1.20
Public 2.10 1.90 0.30 0.30 0.20 0.10
Others 32.10 32.10 32.10 32.10 32.20 32.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: